ANIX - Anixa Biosciences Inc

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Anixa Biosciences initiates phase 1 trial of its ovarian cancer CAR-T therapy
• Anixa says new protease inhibitor outperformed main agent in Pfizer’s COVID-19 pill
• Anixa Bio says its COVID-19 compounds are expected to be effective against Omicron variant
• Anixa Biosciences gets dosing underway in breast cancer vaccine study
• Anixa Biosciences nabs first Chinese patent for CAR-T cancer therapy technology
• Anixa Bio nabs new U.S. patent for its CAR-T cancer therapy (duplicate)
• Anixa Biosciences gets notice of allowance for additional patent on its CAR-T cancer therapy
• Anixa Bio gets FDA green light to initiate trial of ovarian cancer CAR-T immunotherapy
• Anixa Biosciences' COVID-19 compounds show promise against Delta variant
• OntoChem assigns Anixa covid-19 drug discovery project to MolGenie
• Anixa Biosciences places CAR-T therapy study on hold
• Twist Bioscience and Codexis in focus as Piper Sandler upbeat on synthetic biology, and more in today’s analyst action
• Anixa advancing COVID-19 antiviral candidates to preclinical stage
• Anixa Biosciences plunges on upsizing stock offering to $22.5M
• Anixa Biosciences to raise $10M in bought deal offering
• Anixa Bio shares surge 35% on European patent for ovarian cancer vaccine technology
• Anixa issued European patent for CAR-T cancer therapy
• Anixa Biosciences, Cleveland Clinic in ovarian cancer vaccine pact
• Seeking Alpha Catalyst Watch
• Anixa nabs European patent covering CAR-T technology